It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

A clinical trial at Stanford Medicine has shown that CAR-T cell therapy, a cancer treatment, can effectively treat brain ...

Investigators at Dana-Farber Cancer Institute are opening a new clinical trial to evaluate a novel type of immune cellular ...

In a remarkable medical breakthrough, doctors have successfully used stem cells to treat a debilitating eye condition that ...

As Sri Lanka's healthcare system struggles to get back on its feet following the election of a new president in September, ...

Cordyceps militaris, also known as caterpillar fungus, zombifies ground-dwelling insect larvae. They feast on the critter ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

The ascension of Robert F. Kennedy Jr., a longtime anti-vaccine activist, to the nation’s top health post has alarmed medical ...

Actor Dave Coulier, known for playing Uncle Joey on the TV series Full House, announced he has stage 3 non-Hodgkin's lymphoma ...

The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...